Linoleoyl-lysophosphatidylcholine suppresses immune-related adverse events due to immune checkpoint blockade.

MLA

Mathews, Ian T., et al. “Linoleoyl-Lysophosphatidylcholine Suppresses Immune-Related Adverse Events Due to Immune Checkpoint Blockade.” MedRxiv : The Preprint Server for Health Sciences, Aug. 2024. EBSCOhost, https://doi.org/10.1101/2024.08.07.24310974.

APA

Mathews, I. T., Saminathan, P., Henglin, M., Liu, M., Nadig, N., Fang, C., Mercader, K., Chee, S. J., Campbell, A. M., Patel, A. A., Tiwari, S., Watrous, J. D., Ramesh, K., Dicker, M., Dao, K., Meyer, M. A., Jousilahti, P., Havulinna, A. S., Niiranen, T., … Sharma, S. (2024). Linoleoyl-lysophosphatidylcholine suppresses immune-related adverse events due to immune checkpoint blockade. MedRxiv : The Preprint Server for Health Sciences. https://doi.org/10.1101/2024.08.07.24310974

Chicago

Mathews, Ian T, Priyanka Saminathan, Mir Henglin, Mingyue Liu, Namratha Nadig, Camille Fang, Kysha Mercader, et al. 2024. “Linoleoyl-Lysophosphatidylcholine Suppresses Immune-Related Adverse Events Due to Immune Checkpoint Blockade.” MedRxiv : The Preprint Server for Health Sciences, August. doi:10.1101/2024.08.07.24310974.